Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04298567
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2020-02-19
Brief Title:
Study to Learn More About the Safety and Effectiveness of Rivaroxaban Xarelto When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart CAD andor With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms Symptomatic PAD
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-06
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-19
First Submit QC Date:
March 5 2020
Study First Post Date:
2020-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-27
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL